Stock screenerAll disclosures →
EDGAR →
EVMN
Conviction 28HealthcareScan · Thu, Jun 25, 2026Bullish harami
EVMN$24.10+2.29%
ResistanceSupportVol 14Insider sell2
2
2
Vol MA14 557.57K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price24.10
Change+2.29%
Gap+0.06%
Rel volume0.99×
Avg volume513.26K
Avg $ vol11.11M
SMA 2021.40
SMA 5023.13
SMA 200—
Price vs 50+4.20%
Price vs 200—
MA stack—
50/200 cross—
Supertrendup · 19.73
RSI (14)60
MACD hist0.54
MACD crossbull · 5d
Stoch %K / %D77 / 80
ADX (14)18
+DI / −DI28 / 10
RSI divergence—
MACD divergence—
ATR %+6.41%
ADR %6.85%
52w high31.57
52w low15.01
From 52w high-23.66%
Above 52w low+60.56%
New 52w highNo
SqueezeOff
Bollinger width28.30%
%B0.95
Donchian pos77.28%
Donchian high25.52
Donchian low19.27
AVWAP (52w high)25.44
vs AVWAP high-5.27%
AVWAP (52w low)24.25
vs AVWAP low-0.62%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d0.99×
Avg vol (14d)557.57K
Avg vol (20d)513.26K
Avg $ vol (20d)11.11M
Market cap868.04M
RS 3m (vs SPY)-0.17%
RS 6m (vs SPY)+21.36%
RS line new highNo
Trend template—
Technical rank82.3
1 week+16.71%
1 month+3.21%
3 months+4.19%
6 months+40.85%
1 year—
YTD+39.23%
P/E-12.60
P/B2.85
P/S66.77
P/FCF-11.32
EPS-11.22
Div yield—
ROE-22.61%
ROA-21.36%
Debt/Eq—
Current20.36
EV/EBITDA-10.19
Gross margin—
Net margin-529.77%
Rev growth85.71%
EPS growth-3.09%
Price target51.80
Target upside114.94%
Analyst ratingBuy
Institutional97.91%
Ent. value819.72M
Revenue0
Net income-21.67M
Gross profit—
Free cash flow-76.68M
IndustryBiotechnology
ExchangeNYSE
Shares out36.02M
Employees48
ListedThu, Nov 6, 2025
Free float10.05M
Float %31.9%
Short interest3.98M
Days to cover9.2d
Short volume36.0%
Squeeze score65 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.68 · 3 est
Last EPS vs est−$0.64 vs −$0.83
Last surprise+22.9% beat
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank82.3 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in EVMN
No recent disclosed trades by Congress in EVMN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EVMN · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cohen David E Director · Common Stock · 2026-06-02 | Sell | 600 | $13K | 2026-06-02 | 2026-06-03 |
Cohen David E Director · Stock Option (Right to buy) · 2026-06-02 | Grant | 15.67K | $0 | 2026-06-02 | 2026-06-03 |
KIRSCH ARTHUR S Director · Stock Option (Right to buy) · 2026-06-02 | Grant | 15.67K | $0 | 2026-06-02 | 2026-06-03 |
Cohen David E Director · Common Stock · 2026-06-02 | Sell | 5.46K | $110K | 2026-06-02 | 2026-06-03 |
MCGRAW BENJAMIN F III Director · Stock Option (Right to buy) · 2026-06-02 | Grant | 15.67K | $0 | 2026-06-02 | 2026-06-03 |
Patel Jeegar Pravinkumar Chief Scientific Officer · Employee Stock Option (Right to Buy) · 2026-06-01 | Exercise | 13.51K | $0 | 2026-06-01 | 2026-06-03 |
Pena Luis C. President & CEO · Common Stock · 2026-06-01 | Sell | 16.79K | $382K | 2026-06-01 | 2026-06-03 |
Patel Jeegar Pravinkumar Chief Scientific Officer · Common Stock · 2026-06-01 | Sell | 16.69K | $379K | 2026-06-01 | 2026-06-03 |
Patel Jeegar Pravinkumar Chief Scientific Officer · Common Stock · 2026-06-01 | Exercise | 13.51K | $52K | 2026-06-01 | 2026-06-03 |
Carver Kyle Chief Financial Officer · Common Stock · 2026-05-28 | Sell | 18.18K | $415K | 2026-05-28 | 2026-06-01 |
SEC filings
EDGAR filings in EVMN · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.